Results 191 to 200 of about 422,721 (328)
This pilot physiological study, involving 20 patients with severe aortic stenosis, shows that transcatheter aortic valve implantation (TAVI) induces rapid changes in both macrocirculatory parameters, reflecting the release of chronic obstruction. We observed improved tissue perfusion by postoperative Day 1, independent of macrocirculatory parameters ...
Stanislas Abrard +12 more
wiley +1 more source
Evaluation and Management of Recurrent Atrial Flutter in Neonates. [PDF]
Aravindan N, Gaskin PRA, Vashist S.
europepmc +1 more source
Flowchart and inclusion/exclusion criteria for Criptofast Study. Patients were separated into two groups depending on the normal/abnormal left atrium, and all of them were early randomized to standard of care versus internal loop recorder implantation, searching for new onset atrial fibrillation at 12 months follow up.
E. Vallès +13 more
wiley +1 more source
Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter
U. Celikyurt +7 more
semanticscholar +1 more source
ABSTRACT Introduction Safe and effective left atrial (LA) access is a critical step in catheter ablation procedures. While radiofrequency wire (RFW)‐based transseptal puncture (TSP) offers advantages over mechanical needle (MN) techniques, adoption in Europe has been limited due to concerns about the need for costly adjunctive imaging.
Victor Javier Ceseña‐Báez +5 more
wiley +1 more source
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen +4 more
wiley +1 more source
Typical atrial flutter with atypical electrocardiogram morphology: electrophysiology and atrial anatomic characteristics. [PDF]
Yang JD +7 more
europepmc +1 more source
ABSTRACT The goal of a cardiac pulsed field ablation (PFA) system is to provide safe, effective, and usable therapy for the treatment of cardiac arrhythmias. Achieving this goal is a complex exercise in system design, requiring optimization of catheter, waveform, and dosing. This optimization is often iterative, as myriad design factors are balanced to
Brendan Koop
wiley +1 more source

